WITHDRAWN: Efficacy of thermobalancing therapy for chronic prostatitis/chronic pelvic pain syndrome, confirmed by clinical study, may suggest etiology and pathophysiology of this disease

Allen, Simon; Aghajanyan, Ivan Gerasimovich

doi:10.5489/cuaj.4473

Cited by 3 publications

(2 citation statements)

References 7 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, most researchers did not pay attention to changes in blood flow in men with CP/CPPS. The use of DADT by keeping the source of body temperature in the projection of the prostate gland for a prolonged period has deactivated the micro-focus of hypothermia and ischemia, thereby relieving the pressure in the prostate tissue and pain [ 36 ]. We also investigated the influence TT on BPH and guided that improvement of blood circulation at the capillary level plays a crucial role in its cause [ 37 ].…”

Section: Discussionmentioning

confidence: 99%

The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy

Allen

2017

Diseases

Self Cite

View full text Add to dashboard Cite

Chronic pain in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), NIH category III is difficult to treat without understanding its cause. The main symptom of chronic prostatitis is pain. In this study, we would like to explain the origin of pain in men with CP/CPPS and its therapy. Forty-five patients with CP/CPPS have received thermobalancing therapy (TT) enabled by Dr Allen’s therapeutic device (DATD) for six months as mono-therapy. The control group comprised 45 men with CP/CPPS did not receive TT. Before and after six months the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scores, prostatic volume (PV) by ultrasound measurement and uroflowmetry (Qmax) were compared between the groups. Baseline characteristics have shown no difference. After TT, significant improvements in pain score (p < 0.001), quality of life index (QoL) (p < 0.001), decrease of PV (p < 0.001), and increase Qmax (p < 0.001) were determined. There were not noteworthy changes in the control group. Chronic pain due to CP/CPPS happens as a consequence and challenges at the capillary level, namely pathological capillary activity. In response to initial triggers—such as inflammation, cold, psychological and other factors—constriction and spontaneous expansion of capillaries follows, creating a continuous secondary trigger—i.e., the micro-focus of hypothermia—which in turn provokes expansion of capillaries. The additional tissue due to vascular changes into the prostate increases pressure on nociceptors causing pain. TT relieves chronic pelvic pain by eliminating the lasting focus of hypothermia in the affected prostate tissue.

show abstract

Section: Discussionmentioning

confidence: 99%

The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy

Allen

2017

Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

“…The self-management of LUTS due to BPH with the use of DATD demonstrated its high efficacy [46]. It was also proved to be effective in treatment of chronic prostatitis and chronic pelvic pain, which may be responsible for the development of BPH [47,48]. Therefore, implementation TT with DATD as the first-line BPH treatment into the Guideline for Urologists and General Practitioners should be carried out as soon as possible.…”

Section: Benign Prostatic Hyperplasiamentioning

confidence: 99%

Thermobalancing Therapy® should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences

2017

ARC Journal of Urology

View full text Add to dashboard Cite

Background: The prevalence of kidney stone disease is increasing around the world, notonly in men but in women. All surgical removals of kidney stones, such as extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL) have serious side effects and complication. There are parallel undesirable problems in men after conventional treatments of benign prostatic hyperplasia (BPH) with medications and surgery. At the same time Thermobalancing therapy (TT) enabled by Dr Allen's therapeutic device (DATD) has demonstrated positive impact on chronic internal diseases. Therefore, these issues were discussed at the Nephrology Conference in Spain and at the Global Health Conference in China, in October-November 2017.The purpose of this review is to talk about the key points of discussions at these conferences and proposals for the future. Methods and Results: The case study on TT with DATD in patient with kidney stones; and the outcomes from the clinical trial on TT in 124 men with BPH, before and after 6-month period they used DATD. TT with DATD dissolved kidney stones in a woman; reduced Prostate Volume (PV mL) (P<0.001) and diminished urinary symptoms (P<0.001) in men with BPH. Conclusion: The implementations of TT with DATD for the treatment of kidney stone disease were the key note discussions at the Medical Conferences. For over 7 years TT with DATD has been given for hundreds of sufferers with kidney stone disease and thousands with BPH. The results of the case study and clinical trial recommend TT with DATD for kidney stone disease and BPH as the first line treatment. This will help patients to avoid BPH medication and surgical procedures, including ESWL and PCNL, with their risks and complications. Furthermore, DATD should be introduced into the Guidelines for Medical Specialist for men with BPH and people with kidneys stones disease

show abstract

Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome

Wazir

Ullah

et al. 2019

Int Urol Nephrol

View full text Add to dashboard Cite

WITHDRAWN: Efficacy of thermobalancing therapy for chronic prostatitis/chronic pelvic pain syndrome, confirmed by clinical study, may suggest etiology and pathophysiology of this disease

Abstract: Allen et al: Etiology of chronic prostatitis

Cited by 3 publications

References 7 publications

The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy

The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy

Thermobalancing Therapy® should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences

Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome

Contact Info

Product

Resources

About